Searched for
DAVID REDFERN
Canada’s anti-Musk pivot hits Starlink’s second-biggest marketOntario Premier Doug Ford scrapped a contract with Elon Musk's Starlink in response to US tariffs, posing a dilemma for Canadians reliant o...- Teams to plan staff integration or separation in GSK-HUL dealGSK chief strategy officer said there is no clause in the deal that HUL has to retain all GSKCH employees.
- HUL to pour Horlicks into its portfolio with GSK dealUnilever edged past Nestle, the world’s largest food and drinks company, in a closely fought battle.
- GSK raises India unit stake to 75% via open offerWe are very pleased with the outcome of this transaction, which further increases our exposure to a strategically important market," GSK Ch...
- GlaxoSmithKline to spend $1 billion to raise stake in Indian pharma unitGSK said that it was looking to buy a 24% stake in the pharmaceuticals subsidiary for about $1billion or Rs 6,400 crore.
- India is a strategically important market for us: David Redfern, GSK Plc"As India develops, there will be a growing focus on more medicines and vaccines which are required," Redfern said.
- GlaxoSmithKline Consumer Healthcare lines up 5,222 crore share buyback offerThe UK-based company plans to raise stake in Indian unit by 31.8 per cent through an open offer at a 28 per cent premium.
- UK-based healthcare major GlaxoSmithKline to invest Rs 5,220 cr in India subsidiaryGlaxoSmithKline today announced plans to infuse about Rs 5,220 crore in its Indian subsidiary GSKCH by increasing stake to 75% from 43.2% a...
- Want to make stake raising offer attractive for GSK Consumer shareholders: David Redfern, GSK"We have been obviously launching the offer to acquire up to 75% and what we think is hopefully an attractive premium for the current share...
- GSK to raise stake in GlaxoSmithKline Consumer Healthcare via open offerGlaxoSmithKline plans to raise its stake in its Indian consumer products arm to 75 per cent from 43.16 per cent through an open offer.
Load More
